Ads
related to: cll could be treated outpatient- CLL/SLL Dosing Guidelines
Get Dosing & Prescribing Info
For A CLL Treatment.
- Educational Materials
Find A Selection Of Resources To
Help Your Patients With CLL
- CLL/SLL Efficacy Data
Find Data From Clinical
Trials Of A CLL/SLL Treatment
- Mechanism Of Action
Learn More About Treatment-Related
Lymphocytosis In A CLL Trial
- Patient Support Program
Offers Information & Resources Your
Patients May Need During Treatment.
- CLL/SLL Safety Data
Find Important Safety
Information Of A CLL/SLL Treatment
- CLL/SLL Dosing Guidelines
Search results
Results from the WOW.Com Content Network
Treatment. CLL treatment focuses on controlling the disease and its symptoms rather than on an outright cure. In those without or only minimal symptoms watchful waiting is generally appropriate. CLL is treated by chemotherapy, radiation therapy, biological therapy, or bone marrow transplantation.
CLL/SLL is the most common adult leukemia in Western countries, accounting for 1.2% of the new cancers diagnosed each year in the United States. It usually occurs in older adults (median age at diagnosis 70) and follows an indolent course over many years. About 1-10% of CLL/SLLs develop a Richter's transformation at a rate of 0.5–1% per year.
Alemtuzumab is used for the treatment of B-cell chronic lymphocytic leukemia in people who have been treated with alkylating agents and who have failed fludarabine therapy. It is an unconjugated antibody, thought to work via the activation of antibody-dependent cell-mediated cytotoxicity .
The diagnosis of MBL in these patients depends on finding 0.5-5x10 9 monoclonal B cells that express the makers characteristic of CLL/SLL MLB, atypical CLL/SLL MLB, non-CLL/SLL MLB, or MLB-MZ. However, individuals with CBL-MZ commonly present with B-cell blood counts that are extremely high (>4.0x10 9 ; range 3.0x10 9 /L to 37.1x10 9 /L); [2 ...
Most CLL cases are incurable by present treatments, so treatment is directed towards suppressing the disease for many years, rather than curing it. The primary chemotherapeutic plan is combination chemotherapy with chlorambucil or cyclophosphamide , plus a corticosteroid such as prednisone or prednisolone .
Hairy cell leukemia is an uncommon hematological malignancy characterized by an accumulation of abnormal B lymphocytes. [1] It is usually classified as a subtype of chronic lymphocytic leukemia (CLL). Hairy cell leukemia makes up about 2% of all leukemias, with fewer than 2,000 new cases diagnosed annually in North America and Western Europe ...
Ads
related to: cll could be treated outpatient